Jump to content

Roledumab

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by AztecWarrior28 (talk | contribs) at 14:56, 2 March 2018. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Roledumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
TargetRHD
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
 ☒NcheckY (what is this?)  (verify)

Roledumab is a monoclonal antibody. It binds to RHD, the Rhesus factor antigen.[1]

It is currently at Phase III trials for Rh disease.

References

  1. ^ World Health Organization (2010). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 103" (PDF). WHO Drug Information.


Stub icon

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

Stub icon

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Roledumab&oldid=828435930"